| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 52, 111-115, Copyright © 1981 by Endocrine Society
ARTICLES |
TJ Hahn, LR Halstead and DT Baran
These studies were performed to examine the hypothesis that glucocorticoids suppress intestinal calcium absorption in man by decreasing the circulating concentrations of biologically active vitamin D metabolites. Twelve normal adults were equilibrated for 2 weeks on a 600-mg calcium diet. After equilibration, subjects were studied for 12 days before and 14 days during the administration of prednisone (20 mg/day). After 14 days of prednisone administration, intestinal 47Ca absorption had decreased by 31% from initial values (P < 0.001). However, mean serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D did not change significantly from initial values of 28.1 +/- 1.8 and 2.09 +/- 0.17 pg/ml, respectively, and the serum 1,25-dihydroxyvitamin D concentration was slightly increased (baseline, 34.8 +/- 3.3; day 14, 54.0 +/- 7.1 pg/ml; P < 0.02). The fasting serum immunoreactive parathyroid hormone concentration did not change. These results demonstrate that reduced intestinal calcium absorption after glucocorticoid administration cannot be attributed to decreasing circulating concentrations of the major known vitamin D metabolites.
This article has been cited by other articles:
![]() |
Z. Chakhtoura, A. Bachelot, D. Samara-Boustani, J.-C. Ruiz, B. Donadille, J. Dulon, S. Christin-Maitre, C. Bouvattier, M.-C. Raux-Demay, P. Bouchard, et al. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency. Eur. J. Endocrinol., June 1, 2008; 158(6): 879 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kunzendorf, B. K. Kramer, W. Arns, J. Braun, J. Grossmann, F. Pietruck, H. Schmidt-Gayk, A. Schwarz, E. Ziegler, H. Sperschneider, et al. Bone disease after renal transplantation Nephrol. Dial. Transplant., February 1, 2008; 23(2): 450 - 458. [Full Text] [PDF] |
||||
![]() |
S. Huybers, T. H. J. Naber, R. J. M. Bindels, and J. G. J. Hoenderop Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6 Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G92 - G97. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-S. Lee, K.-C. Choi, and E.-B. Jeung Glucocorticoids differentially regulate expression of duodenal and renal calbindin-D9k through glucocorticoid receptor-mediated pathway in mouse model Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E299 - E307. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Rubin and J. P. Bilezikian The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4033 - 4041. [Full Text] [PDF] |
||||
![]() |
R. N. J. de Nijs, J. W. G. Jacobs, J. W. J. Bijlsma, W. F. Lems, R. F. J. M. Laan, H. H. M. Houben, E. J. ter Borg, A. M. Huisman, G. A. W. Bruyn, P. L. M. van Oijen, et al. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis Rheumatology, December 1, 2001; 40(12): 1375 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A McLean, S. I Barr, and J. C Prior Cognitive dietary restraint is associated with higher urinary cortisol excretion in healthy premenopausal women Am. J. Clinical Nutrition, January 1, 2001; 73(1): 7 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Soyka, W. P. Fairfield, and A. Klibanski Hormonal Determinants and Disorders of Peak Bone Mass in Children J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 3951 - 3963. [Full Text] |
||||
![]() |
G. Pearce, D. A. Tabensky, P. D. Delmas, H. W. G. Baker, and E. Seeman Corticosteroid-Induced Bone Loss in Men J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 801 - 806. [Abstract] [Full Text] |
||||
![]() |
J. Rubin, D. M. Biskobing, L. Jadhav, D. Fan, M. S. Nanes, S. Perkins, and X. Fan Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells Endocrinology, March 1, 1998; 139(3): 1006 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Osella, M. Terzolo, G. Reimondo, A. Piovesan, A. Pia, A. Termine, P. Paccotti, and A. Angeli Serum Markers of Bone and Collagen Turnover in Patients with Cushing's Syndrome and in Subjects with Adrenal Incidentalomas J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3303 - 3307. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sambrook, J. Birmingham, P. Kelly, S. Kempler, T. Nguyen, N. Pocock, and J. Eisman Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin N. Engl. J. Med., June 17, 1993; 328(24): 1747 - 1752. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |